Balanced news tone
News Sentiment
TOI sentiment intelligence
Oncology Institute Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+11.6% over one week, +10.9% over four weeks, trend active, and materially above fair value.
TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Microcap Value Benchmark Index
The Oncology Institute, Inc. (NasdaqCM:TOI) has been included in the Russell Microcap Value Benchmark Index. This announcement follows an earlier update about its inclusion in the Russell 2000 Value Benchmark. The Oncology Institute provides value-based oncology services across 8
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 29 Jun 2026 16:12
- Source
- www.marketscreener.com
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?
The Oncology Institute (TOI) shares recently gained 5.3%, contributing to an 8.7% rise over the past four weeks, with high trading volume. The company is expected to report a quarterly loss of $0.07 per share, an improvement of 50% year-over-year, and revenues of $156.15 million,
- Tone
- Positive 62/100
- Event
- Market update
- Published
- 29 Jun 2026 14:12
- Source
- Market source
Oncology Institute (TOI) major holder Jorey Chernett buys 18,000 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Oncology institute ten percent owner Jorey Chernett buys $90k in stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Investing.com Canada
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Market source
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 13:00
- Source
- GlobeNewswire
Insider boosts Oncology Institute (TOI) stake with 38,500-share open-market buys
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 21 May 2026 07:00
- Source
- Stock Titan
Jorey Chernett buys $156,595 of Oncology Institute stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Investing.com
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 13:00
- Source
- GlobeNewswire
The Oncology Institute, Inc. (NASDAQ:TOI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Oncology Institute Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 May 2026 07:00
- Source
- The Globe and Mail
The Oncology Institute Reports First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- GlobeNewswire
The Oncology Institute Inc. (TOI) stock rises on Q1 2026 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Quiver Quantitative
Here’s What Powered The Oncology Institute’s (TOI) Gains
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
Chernett Jorey buys Oncology Institute (TOI) shares worth $157,500
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Investing.com
Oncology Institute (TOI) CMO logs RSU tax-cover share sale on Form 4
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Stock Titan
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 26% Hiding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- simplywall.st
Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jan 2026 08:00
- Source
- simplywall.st
Assessing Oncology Institute (TOI) Valuation After Mark Stolper Joins The Board
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jan 2026 08:00
- Source
- simplywall.st
For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 08:00
- Source
- simplywall.st
The Oncology Institute: Making Progress (NASDAQ:TOI)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Dec 2025 08:00
- Source
- Seeking Alpha
Both individual investors who control a good portion of The Oncology Institute, Inc. (NASDAQ:TOI) along with institutions must be dismayed after last week's 13% decrease
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Nov 2025 08:00
- Source
- simplywall.st